PLK1 (PLK or STPK13) Antibody

About the Target

This antibody supports efforts to analyze PLK1 and interpret it within interaction networks. PLK1 is a pathway component whose activation state and localization can change after stimulation. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

In some datasets and protocols, it is referenced by the gene symbol STPK13.

Research Context

Signaling targets are typically assessed across time courses to capture transient activation windows. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution.

Consider these angles when interpreting target-level changes:

• condition-to-condition comparisons with matched controls
• interaction patterns within multi-protein complexes
• localization shifts between cytoplasm, membrane, and nucleus

Variant Considerations

When assay conditions are still being tuned, a regular-format antibody supports stepwise adjustment of buffers and incubation steps. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

For challenging targets, pairing PLK1 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

If your study spans multiple model systems, it can help to define a shared reference condition for PLK1 so cross-sample contrasts stay meaningful.

If your study spans multiple model systems, it can help to define a shared reference condition for PLK1 so cross-sample contrasts stay meaningful.

Use the regular format version to relate PLK1 behavior to upstream cues and downstream consequences.